Trademark applications and grants for Acadia Pharmaceuticals Inc. Acadia Pharmaceuticals Inc has 41 trademark applications. The latest application filed is for "NUMYTRIS"
Patent Application | Date |
---|---|
COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES 20220298151 - 17/827092 BURSTEIN; Ethan S. ;   et al. | 2022-09-22 |
PIMAVANSERIN FOR TREATING SCHIZOPHRENIA OR FOR TREATING PSYCHOSIS SECONDARY TO NEURODEGENERATIVE DISORDERS OR DEPRESSIVE DISORDER 20220288048 - 17/629098 Kirola; Dragana Bugarski ;   et al. | 2022-09-15 |
MANUFACTURING METHODS AND POLYMORPHS OF A THIAZOLINE ANTI-HYPERALGESIC AGENT 20220267285 - 17/494552 Dax; Scott L. | 2022-08-25 |
SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES 20220241265 - 17/474816 Weiner; David M. ;   et al. | 2022-08-04 |
FORMULATIONS OF PIMAVANSERIN 20220193057 - 17/693830 Tejwani; Ravindra ;   et al. | 2022-06-23 |
NCAGE Code | 5LB84 | ACADIA PHARMACEUTICALS INC. |
CAGE Code | 5LB84 | ACADIA PHARMACEUTICALS INC. |
S.A.M. Registration | 5LB84 [963571302] | ACADIA PHARMACEUTICALS INC. |
SEC | 0001070494 | ACADIA PHARMACEUTICALS INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.